An interventional study of 1 Periacetabular osteotomy in Osteoarthritis, sponsored by University of Aarhus. Completed at 1 site in Denmark. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2008-02-12.
Sponsored by University of Aarhus · Not applicable, Interventional, and Treatment
The purpose of this study is to evaluate the effect of performing a periacetabular osteotomy on patients with hip dysplasia.
The cause of osteoarthritis in hip dysplasia is thought to be attributable to increased joint contact pressures secondary to decreased acetabular coverage of the femoral head and/or incongruity of the articular surfaces. The investigators' hypothesis is that when periacetabular osteotomy is performed and contact pressure on cartilage reduced, additional joint degeneration will be slowed or prevented unless irreparable damage to the cartilage has happened at the time periacetabular osteotomy is performed. Hence, the purposes of this study are:
4,398 studies on the registry are indexed under Osteoarthritis; 582 are open to participants now.
This study's enrollment of 35 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →University of Aarhus is the lead sponsor of 1,274 studies on the registry; 183 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Procedure: 1 Periacetabular osteotomy
pelvic osteotomy to increase acetabular coverage
Also known as: periacetabular osteotomy
migration of acetabulum
Time frame: six months
BMD in acetabulum
Time frame: within two and a half year
status of labrum
Time frame: three years after pelvic osteotomy
changes in cartilage thickness
Time frame: two and half a year
This study is completed, as verified in Jan 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Aarhus